At Prospect Biosystems our expertise is to provide biomarker solutions
for drug discovery, diagnostics and disease management. We have developed a broad-range biomarker discovery capability and instrumentation platform, driven from our expertise.
Since Proteomics links genes, proteins and disease, it has the potential to play an important part in drug discovery and development. Using Edge Technology, a disease process can be characterized by finding a protein or groups of proteins that together participate in causing it.
Similarly, Edge Technology can be used to evaluate the effects of candidate drugs intended to mediate or cure a disease. Many drugs act by targeting proteins or are themselves proteins. Likewise, many markers of disease, the basis of diagnostics, are proteins.